Rexahn Pharmaceuticals, Inc. (AMEX:RNN) gained 25.26% up to $1.19 on no news; but has been garnering attention from investment researchers this week. RNN stock has gained more than 70% since Monday on heavy volume.  Based in Rockville, Maryland, Rexahn Pharmaceuticals, Inc., is a clinical stage biopharmaceutical company which discovers, develops, and commercializes treatments for cancer, central nervous system disorders, sexual dysfunction in the US. The company currently has three drug candidates in Phase II clinical trials which include Serdaxin for the treatment of depression, Archexin for the treatment of renal cell carcinoma and pancreatic cancer; and Zoraxel for the treatment of sexual dysfunction.

GeoPharma, Inc. (NASDAQ:GORX) gained 11.11% up to $0.301 on no news; however the company is expected to release Q4 results today after the close of the market. . Headquartered in Largo, Florida, GeoPharma researches, develops, manufactures, and brings to market branded generic pharmaceuticals, veterinary products, health products, and functional foods.  The company is registered with both the Food and Drug Administration and the Drug Enforcement Administration.

To be kept up to date on all of our hot stock information join us at Picks That Move.

About PicksThatMove.com:

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies.  PicksThatMove.com is not a registered investment advisor or broker-dealer.  PicksThatMove.com affiliates, officers, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value.  We recommend Due Diligence before investing in any stock. 

Subscribe NOW to our newsletters by clicking on the following link: http://picksthatmove.com/join-now/.   Feel free to visit our communities on Facebook and Twitter

Western Coal Corp. (TSX: WTN), $3.43, +0.28, 8.89%, is making considerable gains today trading near the day’s high of 3.47 touching down on a low of 3.26.  Western Coal released its operating results for the three and nine month period ending December 31, 2009.  Some key points included consolidated revenues of $118.7 million were 10% higher than fiscal second quarter 2010, attributable to 175,000 tonnes of coal sold at previous coal year prices.  Western Coal also reports that they commenced operations on a permit for Maple Coal surface mine which increases reserves of marketable tons to over 10 million short tons, which is a 67% increase in the Maple surface reserves.  Western is a producer of high quality metallurgical and thermal coal from mines located in northeast British Columbia and West Virginia.

Arco Resources Corp. (TSXV: ARR), $0.06, +0.015, 33.33%, is trading in a tight spread between 0.045 and 0.07, coming close to reaching its 52 week-high of 0.075.  The company holds a 100% interest in six mineral claim blocks in Oaxaca, Mexico.  Arco reported on its underground sampling program from its 386 hectare Taviche property.  The results showed a 230 metre long shoot of the vein with silver-gold values averaging 173 g/t silver (Ag) and 1.5 g/t gold (Au).  Other samplings identified a similar 220 metre long shoot averaging 161 g/t Ag and 2.18 g/t Au.  The Tavish vein is a silver-gold-bearing quartz vein.

Rexahn Pharmaceuticals Inc. (AMEX: RNN), $0.76, +0.07, 10.14%, is a clinical stage pharmaceutical company focused on treatments of cancer, CNS disorders, sexual dysfunction and other medical needs.  The company has three drug candidates in Phase II clinical trials, Archexin™, Serdaxin™ and Zoraxel™.  RNN has been trading today between the 0.68 and 0.825 range on gains of over 10%.  Rexahn is presenting today at the 12th Annual BIO CEO & Investor Conference.  Rexhan’s Chairman and CEO, Dr. Chang H. Ahn, will speak about a business overview and provide updates on Rexahn’s recent clinical and financing milestones.

Cord Blood America Inc. (OTCBB: CBAI), $0.01, +0.001, 11.11%, is trading the day away in the range of 0.009 and 0.011, with the 52 week-high sitting at 0.02.  Cord Blood announced yesterday that it has finalized an agreement to process and store cord blood specimens for BioCells, Inc.  BioCells is the second largest stem cell storage company in Argentina with annual revenues of 1.5M (USD) and 12 locations throughout that country.  Cord Blood America facilitates umbilical cord blood stem cell preservation for expectant parents and their children.

Cell Therapeutics Inc. (NASDAQ: CTIC), $0.78, +0.14, 21.88%, focuses on the development, acquisition and commercialization of drugs for the treatment of cancer.  On February 11, 2010, the Cell Therapeutic’s team will host a conference call to review the Company’s 2009 fourth quarter and year-end achievements and financial results.  Cell Therapeutics is trading between 0.74 and 0.80, with its 52 week-high sitting at 2.23.

About Picksthatmove.com

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies. PicksThatMove.com is not a registered investment advisor or broker-dealer. PicksThatMove.com’s affiliates, offices, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value.  Please follow us on Twitter and Facebook for further investment updates.  We recommend you do your own Due Diligence before investing in any of the stocks mentioned above.

CombinatoRx, Incorporated (NASDAQ:CRXX) rose 11.22% up to $1.19 on news; however the company expects an answer on February 22nd from the FDA regarding a review of the New Drug Application for Neuromed’s drug candidate Exalgo for pain management.  CRXX is trading above its 200 day moving average of $1.06.  Based in Cambridge, Massachusetts, CombinatoRx, Inc., is a biopharmaceutical company which discovers, develops, and out-licenses combination pharmaceuticals created by blending drugs to treat various diseases, cancer, metabolic diseases, inherited diseases, and other medical conditions.

OXiGENE, Inc. (NASDAQ:OXGN) gained 10.81% up to $1.23 on no news. Headquartered in Waltham, Massachusetts, OXiGENE, Inc., is a biopharmaceutical company developing small-molecule therapeutics to treat cancer and eye diseases in the US. It focuses on the development and commercialization of drug candidates that disrupt abnormal blood vessels associated with solid tumour progression and visual impairment in ocular diseases

To be kept up to date on all of our hot stock information join us at Picks That Move.

About PicksThatMove.com:

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies.  PicksThatMove.com is not a registered investment advisor or broker-dealer.  PicksThatMove.com affiliates, officers, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value.  We recommend Due Diligence before investing in any stock. 

Subscribe NOW to our newsletters by clicking on the following link: http://picksthatmove.com/join-now/.   Feel free to visit our communities on Facebook and Twitter

Cortex Pharmaceuticals (AMEX:CORX) gained 20.00% up to $0.12 on news the company announced a private placement of $1.5 million in a promissory note by Samyang Optics Co., Ltd. The note accrues interest at the rate of 6% per annum and may be converted into Cortex’s common stock at Samyang’s option at any time after April 15, 2010 and if not converted may be subject to repayment at its maturity date on January 15, 2011. The number of common shares issuable upon conversion of the note shall be based upon the greater of market price per share at closing or a 15% discount to the market price of the common stock at the conversion date. Based in Irvine, California, Cortex Pharmaceuticals, Inc. discovers, develops, and commercializes pharmaceuticals for the treatment of neurological and psychiatric disorders.

Oculus Innovative Sciences, Inc. (NASDAQ:OCLS) rose 15.36% up to $2.21 on no news. Based in Petaluma, California, Oculus Innovative Sciences is a biopharmaceutical company which develops, manufactures and markets products based upon Microcyn Technology platform, including formulations designed to significantly reduce the need for antibiotics to fight infections.

To be kept up to date on all of our hot stock information join us at Picks That Move.

About PicksThatMove.com:

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies.  PicksThatMove.com is not a registered investment advisor or broker-dealer.  PicksThatMove.com affiliates, officers, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value.  We recommend Due Diligence before investing in any stock. 

Subscribe NOW to our newsletters by clicking on the following link: http://picksthatmove.com/join-now/.   Feel free to visit our communities on Facebook and Twitter

Pacific Ethanol Inc. (NASDAQ: PEIX), $2.58, +1.155, 81.06%, is a producer and seller of ethanol and its co-products which include wet distillers grain and is also responsible for providing transportation, storage and delivery of ethanol within the Western United States.  PEIX hit a high today of 2.65 surpassing its previous 52 week-high of 1.50.  The company announced that its plant in Burley has resumed production after being shut down for about a year, amid falling corn prices and sharp market declines.

Eastern Platinum Limited (TSX: ELR), $1.30, +0.06, 4.84%, is a platinum group metals producer.  The company is currently engaged in the acquisition, development and mining of platinum group metal deposits in South Africa.  Shares of ELR have been steadily climbing.  The stock is trading up for the 6^th trading day in a row.  ELR surpassed its 52 week-high today to 1.39 from 1.25.  Eastern Platinum has made the list of hot picks for 2010 by Raymond James.

Adventrix Pharmaceuticals Inc. (AMEX: ANX), $0.447, +0.112, 33.52%, is a biopharmaceuticals company focused on developing and commercializing proprietary product candidates for the treatment of cancer.  ANX has been on the climb, reaching a high of 0.485, just pennies away from its 52 week-high from this December of 0.50.  ANX is heaviest traded on the AMEX today.  Last company announcement was on the completion of its previously announced sale of shares of its Series E convertible preferred stock for gross proceeds of approximately $19 million.

Advaxis Inc. (OTCBB: ADXS), $0.153, +0.01, 6.64%, is a biotechnology company focusing on using multiple mechanisms of immunity with the intent to develop cancer vaccines that are more effective and safer than existing vaccines.  The company is mainly focused on its Listeria monocytogenes cancer vaccine.  ADXS has been on the rise trading up for the fourth consecutive day, reaching the day’s high of 0.158.  the 52 week-high stands at 0.21 from last May.  Advaxis is attending the Sidoti Microcap 2010 Investor Conference today. 

Afri-Can Marine Minerals Corporation (TSXV: AFA), $0.215, +0.015, 7.50%, is the heaviest traded company on the TSX Venture Exchange making gains of 7% and surpassing its 52 week-high of 0.21 to hit a new high of 0.24.  Afri-Can is a marine diamond exploration and development company with its main operations off the coast of Namibia.  Last company announcement was that it retained the services of AGORACOM Investor Relations to supplement and enhance current investor relations services provided by Paradox Investor Relations.

About Picksthatmove.com

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies. PicksThatMove.com is not a registered investment advisor or broker-dealer. PicksThatMove.com’s affiliates, offices, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value.  Please follow us on Twitter and Facebook for further investment updates.  We recommend you do your own Due Diligence before investing in any of the stocks mentioned above.

NexMed, Inc. (NASDAQ:NEXM) gained 20.03% to close at $0.288 on no news.  In November we reported that NexMed will acquire Bio-Quant Inc, a company which conducts in vitro and in vivo contract drug discovery and pre-clinical development services.  The deal is valued at $12.1 million and is expect to close on December 31, 2010. Headquartered in East Windsor, New Jersey, NexMed, Inc. develops bio-enhancement drug delivery technology known as NexACT, which enables an active drug to be better absorbed through the skin. 

Cyclacel Pharmaceuticals Inc. (NASDAQ:CYCC) jumped 18.56% to close at $0.990 with 2,427,593 shares moving today.  Earlier this week the company announced  1-year survival data from a Phase 2 randomized trial of oral Sapacitabine capsules, in elderly patients with acute myeloid leukemia.  This is a substantial discovery considering that patients usually die within 6 month of diagnosis. Headquartered in Berkeley Heights, New Jersey, Cyclacel Pharmaceuticals, Inc., a development-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel, mechanism-targeted drugs to treat human cancers and other serious disorders.  The company currently has 3 drug candidates in 7 clinical trial studies for the treatment of various cancers.  The company’s stock has gained 253% since last December.

To be kept up to date on all of our hot stock information join us at Picks That Move.

About PicksThatMove.com:

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies.  PicksThatMove.com is not a registered investment advisor or broker-dealer.  PicksThatMove.com affiliates, officers, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value.  We recommend Due Diligence before investing in any stock. 

Subscribe NOW to our newsletters by clicking on the following link: http://picksthatmove.com/join-now/.   Feel free to visit our communities on Facebook and Twitter

Uroplasty, Inc. (AMEX:UPI) gained 37.98% up to $1.56 on no news; however the medical device company published results of a 12-month independent  study of its Urgent PC Neuromodulation System that will be printed in the January 2010 edition of Journal of Urology. The Urgent PC System is a patented nerve stimulation device designed for office-based treatment of incontinence and overactive bladder. According to the study 96% of patients considered their urinary symptoms cured or improved at 12 months.  Patients recorded significant decrease in symptoms and an overall improvement in quality of lie. Headquartered in Minnetonka, Minnesota, Uroplasty, Inc. is a medical device company which develops, manufactures, and markets products for the treatment of incontinence and human waste voiding and evacuation dysfunctions.  The company has gained 105% since June.

Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) soared 32.63% up to $0.796 on news the company provided an update of its Phase 2 Voreloxin study for the treatment of leukemia.  The study tested three variations of dosage and found that patients who dosed Voreloxin combined with a standard chemotherapy drug had higher had a median survival rate.  Based on the findings the company has assessed the appropriate tolerable dosage to heighten efficacy and will continue their development of the cancer inhibitor drug candidate.  Sunesis said patients with acute myeloid leukemia usually live for only about three to six months. Headquartered in South San Francisco, California, Sunesis Pharmaceuticals, Inc is a biopharmaceutical company, focuses on the development and commercialization of oncology therapeutics for hematologic and solid tumour cancers. Its primary product candidate is Voreloxin, an anticancer treatment is in Phase 2 development stage.  The company has gained 374% from a 52 week low when the stock was trading at $0.165 in April.

To be kept up to date on all of our hot stock information join us at Picks That Move.

About PicksThatMove.com:

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies.  PicksThatMove.com is not a registered investment advisor or broker-dealer.  PicksThatMove.com affiliates, officers, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value.  We recommend Due Diligence before investing in any stock. 

Subscribe NOW to our newsletters by clicking on the following link: http://picksthatmove.com/join-now/.   Feel free to visit our communities on Facebook and Twitter

Calgary, Alberta - PicksThatMove.com opines promising trading opportunities with likely potential for gain. The companies we follow have favourable revenue models for business development at upward cycles.  Please visit us at PicksThatMove.com to view more of our profiled stocks.

Biopharmaceuticals With A Prescription For Gains: NABI, DCGN

The hot stock information of the day includes:  NABI, DCGN

Nabi Biopharmaceuticals (NASDAQ:NABI) advanced 26.12% up to $4.49 on news the company announced an exclusive worldwide licensing agreement for its nicotine conjugate candidate vaccine NicVAX, with GlaxoSmithKline. The investigational vaccine treats nicotine addiction and helps prevent smoking relapse.  GlaxoSmithKline will pay Nabi $40 million at closing and Nabi will receive an option to receive over $500 million in fees, development and sales milestones for NicVAX and follow-on nicotine vaccines. Nabi will also receive double-digit royalties on global sales of NicVAX should GlaxoSmithKline exercise its option and royalties on global sales of next generation nicotine vaccines.  Headquartered in Rockville, Maryland, Nabi Biopharmaceuticals is a biopharmaceutical company which develops therapeutics and vaccines for nicotine addiction and infectious disease in the US. The company currently has four drug candidates in trials.

deCODE genetics, Inc. (NASDAQ:DCGN) gained 19.30% up to $0.239 on no news. Based in Reykjavik, Iceland, deCODE is a biopharmaceutical company applying its discoveries in human genetics to the development of drugs and diagnostics for common diseases.  Their discoveries created DNA-based diagnostic tests to detect variations in the human genome DNA which have isolated risks linked to prostate cancer, breast cancer, glaucoma, type 2 diabetes, skin cancer, lung cancer and osteoporosis.  The company currently has three drug candidates in trials for the treatment of cardiovascular diseases.

To be kept up to date on all of our hot stock information join us at Picks That Move.

About PicksThatMove.com:

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies.  PicksThatMove.com is not a registered investment advisor or broker-dealer.  PicksThatMove.com affiliates, officers, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value.  We recommend Due Diligence before investing in any stock. 

Subscribe NOW to our newsletters by clicking on the following link: http://picksthatmove.com/join-now/.   Feel free to visit our communities on Facebook and Twitter

American International Group Inc. (NYSE: AIG), $37.74, +$1.56, 4.31%, offers a range of insurance and insurance related-activities in and outside the United States.  The company is making gains today, with trading up $1.56.  Earlier this month, AIG announced that it has been profitable for the second quarter in a row, with Q3 financials revealing a net income available to common shareholders of $92 million, compared to a loss of $24.7 billion during the same quarter last year.  Complete disclosure is posted on the company’s website.

JA Solar Holdings Company Ltd. (NASDAQ: JASO), $4.18, +$0.06, 1.46%, reached a high today of $4.54 today and is presently trading with a volume of over 14.5 million.  JA Solar released its third quarter financial results.  The company reports a revenue of USD $193.3 million, which is a significant increase of 119.6% from its second quarter revenue of $88.0 million, but overall a 37.8% decrease from $310.7 million from the third quarter last year.  Total shipments in Q3 were a record 177megawatts, compared to Q2 of 77megawatts, representing a growth of 129.9%.  JA Solar’s Chairman and CEO, Baofang Jin stated “We are pleased to report the highest quarterly shipments in our company’s history, with increasing demand for our products worldwide.”  JA Solar is a China-based manufacturer of high performance solar cells.

Sinovac Biotech Ltd. (AMEX: SVA), $8.35, +$0.15, 1.83%, conducts business in China, through its subsidiaries, Sinovac Beijing, Tangshan Yian and Sinovac Hong Kong.  Sinovac is a biopharmaceutical company focusing on research, development, manufacturing and commercialization of vaccines which protect against human infectious diseases.  Sinovac will hold a conference call on November 16^th to review the company’s financials and update on recent corporate developments.  Also, as of November 16^th, the SVA symbol will begin trading on the NASDAQ.  Bob McCooey, SVP and Head of Global Listing of NASDAQ OMX Group confirmed that “NASDAQ is the home of innovative biotech and healthcare companies and we are proud to welcome Sinovac, a pioneer in Chinese biotech and engineer of China’s homegrown H1N1 vaccine,”.  SVA is presently trading above its volume of yesterday and at a $0.15 share price increase.

Fresh Harvest Products Inc. (OTCBB:  FRHV), $0.007, +$0.005, 250.00%, is making gains today on no news.  The company is presently trading at a volume of 6.8 million which is truly remarkable compared to yesterday’s close of 500 shares traded. Fresh Harvest, established in 2003, is in the organic food business with its own line of organic coffees, salsas, snack bars and olive oils.  The company develops sells and markets its products through local, regional and national supermarkets and retailers, distributors, brokers, wholesalers and an online Web-store.

Royal Bank of Canada (TSX: RY), $56.70, +$0.26, 0.46%, hit a high of $57.00 today and is presently up $0.21 going into the afternoon.  Royal Bank announced today that it will release its fourth quarter and fiscal 2009 financial results on December 4, 2009.   The results are expected to be released around 6:00 a.m. (EST), followed by a conference call with RY’s executives, at 8:00 a.m.  Royal Bank is one of the largest financial institutions in Canada.  

Calgary, Alberta - PicksThatMove.com opines promising trading opportunities with likely potential for gain. The companies we follow have favourable revenue models for business development at upward cycles.  Please visit us at PicksThatMove.com to view more of our profiled stocks.

CEL-SCI Jumps On Clearance To Proceed With Swine Flu Study

The hot stock information of the day includes:  CVM, HH

CEL-SCI Corporation (AMEX:CVM) jumped 15.32% up to $1.18 with 9,859,587 shares moving on news the company will conduct its first clinical study of the investigational LEAPS-H1N1 candidate for hospitalized H1N1 infected patients at Johns Hopkins University School of Medicine.  The Institutional Review Board of The Johns Hopkins University School of Medicine has granted approval for CEL-SCI Corporation’s first clinical study to proceed.  In September the FDA cleared the way for the company to begin their study to assess the potential of a next-stage clinical trial to evaluate LEAPS-H1N1 treatment of hospitalized patients already infected with the swine flu.  Based in Vienna, Virginia, CEL-SCI Corporation researches and develops drugs and vaccines used in the treatment of cancer and viral infections, the company has been actively researching possible variations and eventual mutations of the swine flu.

Hooper Holmes Inc. (AMEX:HH) surged 25.03% up to $0.95 on news the company reported narrower than expected losses in their Q3 financial results.  Highlights of the report include consolidated revenues of $43.8 million for the third quarter, a decline of a 7% in revenue compared to $47.2 million in the third quarter of 2008; however representing an improvement compared to a decline of 10% the first half of 2009. Headquartered in Basking Ridge, New Jersey, Hooper Holmes, Inc., together with its subsidiaries, provides outsourced risk assessment services to the life and health insurance industry in the US and provides paramedical and medical examinations of applicants for insurance, primarily life insurance, through a network of paramedical examiners, including phlebotomists, registered nurses, licensed practitioner nurses, emergency medical technicians, and other medically trained professionals.

 To be kept up to date on all of our hot stock information join us at Picks That Move.

About PicksThatMove.com:

PicksThatMove.com is an independent electronic publication that provides information on selected publicly traded companies.  PicksThatMove.com is not a registered investment advisor or broker-dealer.  PicksThatMove.com affiliates, officers, directors and employees may buy and sell shares in any company mentioned herein and may profit in the event those shares rise in value.  We recommend Due Diligence before investing in any stock.